Shell Asset Management’s Gilead Sciences GILD Stock Holding History

Shell Asset Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$3.51M	Sell	31,624 -54,965	-63%	-$6.25M	0.35%	47
2025 Q2	$9.6M	Buy	86,589 +22,026	+34%	+$2.34M	0.33%	47
2025 Q1	$7.23M	Sell	64,563 -2,072	-3%	-$214K	0.34%	48
2024 Q4	$6.16M	Sell	66,635 -18,992	-22%	-$1.71M	0.27%	62
2024 Q3	$7.18M	Buy	+85,627	New	+$6.53M	0.32%	59
2024 Q1	$5.86M	Sell	85,455 -3,068	-3%	-$236K	0.27%	66
2023 Q4	$7.17M	Sell	88,523 -20,006	-18%	-$1.56M	0.33%	54
2023 Q3	$8.13M	Sell	108,529 -1,272	-1%	-$97.8K	0.34%	56
2023 Q2	$8.46M	Buy	109,801 +13,585	+14%	+$1.08M	0.33%	56
2023 Q1	$7.98M	Buy	96,216 +180	+0.2%	+$14.9K	0.33%	58
2022 Q4	$8.24M	Buy	96,036 +19,551	+26%	+$1.55M	0.36%	58
2022 Q3	$4.72M	Sell	76,485 -15,348	-17%	-$968K	0.18%	116
2022 Q2	$5.68M	Sell	91,833 -15,092	-14%	-$934K	0.17%	135
2022 Q1	$6.36M	Buy	106,925 +93	+0.1%	+$5.95K	0.15%	146
2021 Q4	$7.76M	Sell	106,832 -58,249	-35%	-$4.01M	0.16%	137
2021 Q3	$11.5M	Sell	165,081 -100,009	-38%	-$7.03M	0.26%	80
2021 Q2	$18.3M	Sell	265,090 -14,348	-5%	-$958K	0.35%	54
2021 Q1	$18.1M	Sell	279,438 -41,476	-13%	-$2.67M	0.36%	58
2020 Q4	$18.7M	Buy	320,914 +88,348	+38%	+$5.33M	0.39%	47
2020 Q3	$14.7M	Sell	232,566 -4,119	-2%	-$286K	0.34%	59
2020 Q2	$18.2M	Buy	236,685 +102,929	+77%	+$7.89M	0.45%	43
2020 Q1	$10M	Sell	133,756 -15,913	-11%	-$1.1M	0.28%	79
2019 Q4	$9.72M	Buy	149,669 +70,810	+90%	+$4.61M	0.21%	124
2019 Q3	$5M	Sell	78,859 -11	-0%	-$719	0.11%	209
2019 Q2	$5.33M	Sell	78,870 -4,913	-6%	-$323K	0.12%	210
2019 Q1	$5.45M	Buy	83,783 +778	+0.9%	+$51.7K	0.12%	213
2018 Q4	$5.19M	Sell	83,005 -11,554	-12%	-$808K	0.13%	197
2018 Q3	$7.3M	Sell	94,559 -5,072	-5%	-$383K	0.14%	171
2018 Q2	$7.06M	Sell	99,631 -24,438	-20%	-$1.73M	0.14%	182
2018 Q1	$9.35M	Buy	124,069 +3,756	+3%	+$299K	0.19%	146
2017 Q4	$8.62M	Buy	120,313 +21,813	+22%	+$1.66M	0.17%	155
2017 Q3	$7.98M	Sell	98,500 -21,005	-18%	-$1.61M	0.18%	160
2017 Q2	$8.46M	Hold	119,505	–	–	0.18%	159
2017 Q1	$8.12M	Sell	119,505 -3,144	-3%	-$221K	0.18%	163
2016 Q4	$8.78M	Sell	122,649 -18,893	-13%	-$1.4M	0.21%	131
2016 Q3	$11.2M	Sell	141,542 -22,257	-14%	-$1.81M	0.23%	119
2016 Q2	$13.7M	Buy	163,799 +23,859	+17%	+$2.12M	0.32%	83
2016 Q1	$12.9M	Sell	139,940 -3,867	-3%	-$349K	0.31%	85
2015 Q4	$14.6M	Sell	143,807 -130,776	-48%	-$13.6M	0.34%	64
2015 Q3	$29.2M	Buy	274,583 +65,910	+32%	+$7.32M	0.46%	36
2015 Q2	$24.4M	Sell	208,673 -23,978	-10%	-$2.62M	0.49%	42
2015 Q1	$22.8M	Sell	232,651 -64,528	-22%	-$6.55M	0.4%	48
2014 Q4	$28M	Buy	297,179 +22,596	+8%	+$2.34M	0.45%	44
2014 Q3	$29.2M	Buy	274,583 +7,854	+3%	+$769K	0.45%	36
2014 Q2	$22.1M	Sell	266,729 -18,314	-6%	-$1.43M	0.34%	57
2014 Q1	$20.2M	Sell	285,043 -1,450	-0.5%	-$114K	0.34%	53
2013 Q4	$21.5M	Sell	286,493 -129,703	-31%	-$9.03M	0.37%	45
2013 Q3	$26.2M	Sell	416,196 -12,132	-3%	-$725K	0.48%	34
2013 Q2	$22M	Buy	+428,328	New	+$22.3M	0.42%	43

Other funds holding GILD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Shell Asset Management's GILD Position: Q3 2025 in Review

Shell Asset Management reduced its Gilead Sciences (GILD) stake by 63% in Q3 2025, selling an estimated $6.25M and leaving 31,624 shares worth $3.51M. The position accounts for 0.35% of the portfolio, ranked #47.

Shell Asset Management first reported a position in GILD in Q2 2013 and has held it in 49 quarters since. The position peaked at $29.2M in Q3 2015. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

Shell Asset Management held 31,624 shares of Gilead Sciences worth $3.51M as of Q3 2025.
Shell Asset Management sold 54,965 Gilead Sciences shares in Q3 2025, an estimated $6.25M.
Gilead Sciences made up 0.35% of Shell Asset Management's portfolio in Q3 2025, its #47 holding.
Shell Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 49 quarters since.
Shell Asset Management's Gilead Sciences position peaked at $29.2M in Q3 2015.
2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Shell Asset Management's 13F filing for Q3 2025, filed 7 Nov 2025.